MedTrace Logo

Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions

NCT01568996 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2018-01-09

No results posted yet for this study

Summary

This is a pilot study to see if oral administration of freeze dried, powdered broccoli sprouts have any effect on whether moles end up becoming melanoma.

Conditions

Interventions

DRUG

broccoli sprout extract - sulforaphane (BSE-SFN)

50 µmol capsules, taken orally, once a day for 28 days

DRUG

broccoli sprout extract - sulforaphane (BSE-SFN)

100 µmol capsules, taken orally, once a day for 28 days

DRUG

broccoli sprout extract - sulforaphane (BSE-SFN)

200 µmol capsules, taken orally, once a day for 28 days

Sponsors & Collaborators

  • John Kirkwood

    lead OTHER

Principal Investigators

  • John M Kirkwood, MD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2016-03-31
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01568996 on ClinicalTrials.gov